Skip to main content
Caplight Logo









MiCAN Technologies Inc.

MiCAN Technologies Inc.

Private
KyotoHealthcare & Life Scienceshttps://www.micantechnologies.com/

Last Round

Series B

Extension

Jan 24, 2025

Total Funding Raised

$5.01M

Company Overview

MiCAN Technologies Inc. is a biotechnology company that develops and supplies human blood cell-based platforms using regenerative medicine technologies to support infectious disease research and pharmaceutical development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

immortalized cell linepyrogen testinganimal-free testingcontract research organizationCROcell-based assayMonocyte Activation TestMATdrug discovery servicessafety assessmentin vitro testingregenerative medicinestem cell technologyvaccine developmentin vitro toxicologycell line developmentpseudovirus

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MiCAN Technologies Inc. Comparables

Compare MiCAN Technologies Inc. with similar companies based on industry and business-model similarity.

MiCAN Technologies Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axol Bioscience
77%
ReproCELL Incorporated
72%
Fujifilm Holdings Corporation
72%

MiCAN Technologies Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJan 24, 2025
Convertible DebtOct 16, 2024
Series BAug 18, 2023
Series AAug 1, 2019

Key People

Founding team and executive leadership

Kazuhisa FUSHIHARA

最高執行責任者, COO CFO

Executive Team

MiCAN Technologies Inc. Investors

Notable investors and investment history

MiCAN Technologies Inc. investors
InvestorRounds
360ip JapanConvertible Debt
MiraidoaSeries B Extension
Osaka University Venture Capital Co., Ltd.Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 14, 2025

    Monthly visitors increased 126% MoM, reaching 4.8K.

  • Jul 22, 2025

    Grew 43% QoQ from 7 to 10 employees.

MiCAN Technologies Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MiCAN Technologies Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MiCAN Technologies Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersKyoto
Employee Range11
Year Founded2016
Last FundingJan 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?